Skip to content
★ Sign in to follow
MS

Michael Scott Mann

Endonovo Therapeutics, Inc.
Total declarations
4,323
Company
1
▲ Purchases (4323 ops.)
€2.1M
▼ Sales (0 ops.)
—

Latest filing published 09 Apr 2019 for ENDONOVO THERAPEUTICS, INC., €75.

Filing timeline

BuySale
Michael Scott Mann

First 200 filings with a declared amount

Insider track record

Disclosed buys
4,323
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4,323
Positive at T+90
38%
Median T+90
-12.8%

Based on 2842 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Michael Scott Mann: trading record in brief

Michael Scott Mann is a declared insider of Endonovo Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 4,323 filings; the first trade dates from 19 August 2015 and the latest from 29 March 2019.

Purchases make up the whole of the open-market record (4,323 purchases, €2.1M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2019 to date brings 76 purchases and no sales.

A typical purchase (the median) is worth €54. Of 2,764 purchases, 32 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 2,842 purchases with a full 90-day history, the hit rate stands at 38% and the median 90-day move at -12.8%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 9 April 2019: an open-market purchase of €75, in Endonovo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Michael Scott Mann

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2,842 total

25 of 2842 declarations